Damasco Paulo Vieira, Solórzano Victor Edgar Fiestas, Fortes Natália Rodrigues Querido, Setta Daniel Xavier de Brito, Fonseca Aloysio Guimaraes da, Perez Mario Castro Alvarez, Jazbick João Carlos, Gonçalves-Oliveira Jonathan, Horta Marco Aurélio Pereira, de Lemos Elba Regina Sampaio, Fortes Claudio Querido
Escola de Medicina e Cirurgia, Departamento de Doenças Infecciosas e Parasitárias, Universidade do Federal do Estado do Rio de Janeiro-UNIRIO, Rio de Janeiro 20271-062, Brazil.
Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro (HUPE/UERJ), Rio de Janeiro 20551-030, Brazil.
Trop Med Infect Dis. 2023 Dec 12;8(12):516. doi: 10.3390/tropicalmed8120516.
Despite advances in diagnosis and treatment, the incidence and mortality of infective endocarditis (IE) have increased in recent decades. Studies on the risk factors for mortality in endocarditis in Latin America are scarce.
This retrospective cohort study included 240 patients diagnosed with IE according to the modified Duke criteria who were admitted to two university hospitals in Rio de Janeiro, Brazil from January 2009 to June 2021. Poisson regression analysis was performed for trend tests. The multivariate Cox proportional hazards model was used to estimate the hazard ratio (HR) of predictors of in-hospital mortality.
The median age was 55 years (IQR: 39-66 years), 57% were male, and 41% had a Charlson comorbidity index (CCI) score > 3. Healthcare-associated infective endocarditis (54%), left-sided native valve IE (77.5%), and staphylococcal IE (26%) predominated. Overall, in-hospital mortality was 45.8%, and mortality was significantly higher in the following patients: aged ≥ 60 years (53%), CCI score ≥ 3 (60%), healthcare-associated infective endocarditis (HAIE) (53%), left-sided IE (51%), and enterococcal IE (67%). Poisson regression analysis showed no trend in in-hospital mortality per year. The adjusted multivariate model determined that age ≥ 60 years was an independent risk factor for in-hospital mortality (HR = 1.9; 95% CI 1.2-3.1; = 0.008).
In this 12-year retrospective cohort, there was no evidence of an improvement in survival in patients with IE. Since older age is a risk factor for mortality, consensus is needed for the management of IE in this group of patients.
尽管在诊断和治疗方面取得了进展,但近几十年来感染性心内膜炎(IE)的发病率和死亡率仍有所上升。拉丁美洲关于心内膜炎死亡率危险因素的研究很少。
这项回顾性队列研究纳入了240例根据改良杜克标准诊断为IE的患者,这些患者于2009年1月至2021年6月入住巴西里约热内卢的两家大学医院。采用泊松回归分析进行趋势检验。多变量Cox比例风险模型用于估计院内死亡预测因素的风险比(HR)。
中位年龄为55岁(四分位间距:39 - 66岁),57%为男性,41%的Charlson合并症指数(CCI)评分>3。医疗保健相关感染性心内膜炎(54%)、左侧自体瓣膜IE(77.5%)和葡萄球菌性IE(26%)占主导。总体而言,院内死亡率为45.8%,以下患者的死亡率显著更高:年龄≥60岁(53%)、CCI评分≥3(60%)、医疗保健相关感染性心内膜炎(HAIE)(53%)、左侧IE(51%)和肠球菌性IE(67%)。泊松回归分析显示每年院内死亡率无趋势。调整后的多变量模型确定年龄≥60岁是院内死亡的独立危险因素(HR = 1.9;95%置信区间1.2 - 3.1;P = 0.008)。
在这项为期12年的回顾性队列研究中,没有证据表明IE患者的生存率有所改善。由于老年是死亡的危险因素,因此需要就这组患者的IE管理达成共识。